What Lundbeck is looking for
Lundbeck is looking for projects and products that can strengthen our position as a leading global CNS company. Our strategy is to achieve this by actively supplementing our internal development with external opportunities.

Therapeutic areas
Our primary licensing interest is in projects and products that expand our range of pharmaceuticals for the treatment of disorders in CNS.

Lundbeck is seeking partnerships within the following areas:

Stages
As a fully integrated pharmaceutical company, Lundbeck is active across all stages of a product’s development. Lundbeck is therefore interested in products at all stages:

• Pre-clinical projects
• Early-stage development projects
• Late-stage development projects
• Registered or marketed products

In order to develop new ground-breaking therapies, Lundbeck is always interested in expanding our R&D capabilities by establishing research and development agreements with external parties.

Types of partnerships
Lundbeck is currently engaged in all types of partnering agreements and is therefore interested in:

• In-licensing opportunities
• Out-licensing opportunities
• Co-development
• Co-promotion, cross-promotion and co-marketing agreements
• Strategic alliances
• Joint ventures

Territories
By being an EU-founded company, Lundbeck has historically had an interest in European rights for products due to our European strength and focus. We are, however, expanding our business in all markets including the US, South America, and Asia.

Geographically we are focused on expanding our presence in all markets and are preferably interested in global or regional partnerships, however partnerships at a country level may also be of interest.